Pharmaceutical counselling on anticoagulation – Identifying needs of German community pharmacies by Laven, Anna et al.
Anna	Laven1,	Fabio	de	Rango2,	Silas	Rydant3,	Filipa	Costa4,	Sotiris	Antoniou5,	on	behalf	of	the	
International	Pharmacists	for	Anticoagulation	Care	Taskforce
1Pharmabrain	GmbH,	Berlin,	Germany,		2	Shoppers	Drug	Mart,	Oakville,	Canada,		3Royal	Pharmacist	Association	(KAVA),	Antwerpen,	Belgium	,	
4Centro	de	InvesQgação	Interdisplinar	Egas	Moniz	(CiiEM);	Portuguese	Pharmaceutical	Society	(PPS),	Portugal,		5Barts	Health	NHS	Trust,	London,	UK	
1.	Background	and	Objectives 3.	Results	
The	role	of	the	community	pharmacist	has	been	
evolving	from	product-focused	to	patient-
oriented1.	In	this	context,	pharmaceutical	
counselling	becomes	especially	important	to	
ensure	safe	and	effective	use	of	drugs2.	This	survey	
is	the	German	arm	of	an	international	survey	
conducted	by	the	international	pharmaceutical	
anticoagulation	care	task	force	(iPACT)3.	
The	objective	is	to	identify	the	educational	needs	
of	German	community	pharmacies	assessed	by	
reported	self-confidence	when	advising	patients	
on	anticoagulants.	
2.	Method
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In	October	and	November	2016	we	conducted	a	
multiple-choice	survey	with	community	pharmacy	
staff	in	Germany.	Data	were	collected	
anonymously.	
In	the	first	part	of	the	survey,	demographic	data	
were	collected.	The	second	part	dealt	with	the	
self-confidence	of	the	participants	when	
counselling	patients	on	
• direct	acting	oral	anticoagulants	(DOAC)
• low	molecular	weight	heparins	(LMWH),	and	
• vitamin	K	antagonists	(VKA),	
the	references	they	used,	their	willingness	to	
receive	additional	education	on	specific	
anticoagulation	topics	and	the	form	of	the	training	
as	well	as	the	support	needed.
Based	on	these	findings,	different	approaches	
should	be	considered	for	pharmacists	and	
pharmacy	technicians	in	order	to	provide	a	
comprehensive,	practice-based	education	
addressing	their	individual	needs.	
Following	any	education	live	or	per	e-learning,	
content	should	be	made	accessible	through	the	
pharmacy	software	in	order	to
assure	sustainability.	
A	total	of	279	questionnaires	were	completed	(206	
pharmacists,	69	pharmacy	technicians	and	three	
others).	
Main	focus	of	interest	for	further	education	were	
interactions	and	their	management	(Pharmacists:	
50,2%,	PT:	32,9%).	Participants	use	information	
from	pharmaceutical	industry	as	a	reference	
(Pharmacists:	70%,	PT:	55,7%),	followed	by	
internet	and	pharmacy	software.	Both	groups	
prefer	seminars/symposia	and	personalized	e-
learnings	as	educational	form	and	would	find	a	list	
of	frequently	asked	questions	supportive.	
The	majority	of	pharmacists	(79,7%,	165)	and	
technicians	(71,4%,	50)	reported	that	information	
should	be	accessible	from	the	pharmacy	software.
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